Cancer incidence in the US military: An updated analysis
Cancer · 2024
DOI: 10.1002/cncr.34978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Julie A Bytnar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Military Personnel, Colorectal Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Background
Military and general populations differ in factors related to cancer occurrence and diagnosis. This study compared incidence of colorectal, lung, prostate, testicular, breast, and cervical cancers between the US military and general US populations.
Methods
Data from the US Department of Defense’s Automated Central Tumor Registry (ACTUR) and the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program were analyzed. Persons in ACTUR were active‐duty members 20–59 years old during 1990–2013. The same criteria applied to persons in SEER. Age‐adjusted incidence rates, incidence rate ratios, and 95% confidence intervals were calculated by sex, race, age, and cancer stage. Temporal trends were analyzed.
Results
ACTUR had higher rates of prostate and breast cancers, particularly in 40‐ to 59‐year‐olds. Further analyses by tumor stage showed this was primarily confined to localized stage. Incidence rates of colorectal, lung, testicular, and cervical cancers were significantly lower in ACTUR than in SEER, primarily for regional and distant tumors in men. Temporal incidence trends were generally similar overall and by stage between the populations, although distant colorectal cancer incidence tended to decrease starting in 2006 in ACTUR whereas it increased during the same period in SEER.
Conclusion
Higher rates of breast and prostate cancers in servicemembers 40–59 years of age than in the general population may result from greater cancer screening utilization or cumulative military exposures. Lower incidence of other cancers in servicemembers may be associated with better health status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
- Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc, Bethesda, Maryland, USA.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
- Department of Surgery, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
- Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
ORCID-Profile: Julie A Bytnar, Katherine A McGlynn, Kangmin Zhu
Förderung
- NCI NIH HHS
Zitieren
APA
Bytnar, J. A., McGlynn, K. A., Nealeigh, M. D., Shriver, C. D., & Zhu, K. (2024). Cancer incidence in the US military: An updated analysis. Cancer. https://doi.org/10.1002/cncr.34978
Vancouver
Bytnar JA, McGlynn KA, Nealeigh MD, Shriver CD, Zhu K. Cancer incidence in the US military: An updated analysis. Cancer. 2024. doi:10.1002/cncr.34978
BibTeX
@article{Bytnar2024,
author = {Bytnar, Julie A and McGlynn, Katherine A and Nealeigh, Matthew D and Shriver, Craig D and Zhu, Kangmin},
title = {Cancer incidence in the US military: An updated analysis},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.34978}
}
EUVIMED